Compile Data Set for Download or QSAR
maximum 50k data
Found 61 of ic50 for UniProtKB: P08514
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228638(US9345793, 19 | US9744252, Example 19)
Affinity DataIC50:  3nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228637(US9345793, 18 | US9744252, Example 18)
Affinity DataIC50:  3nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228634(US9345793, 15 | US9744252, Example 15)
Affinity DataIC50:  5nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228635(US9345793, 16 | US9744252, Example 16)
Affinity DataIC50:  6nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228639(US9345793, 20 | US9744252, Example 20)
Affinity DataIC50:  7nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228632(US9345793, 13 | US9744252, Example 13)
Affinity DataIC50:  7nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228631(US9345793, 12 | US9744252, Example 12)
Affinity DataIC50:  8nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228626(US9345793, 7 | US9744252, Example 7)
Affinity DataIC50:  11nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228630(US9345793, 11 | US9744252, Example 11)
Affinity DataIC50:  14nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228627(US9345793, 8 | US9744252, Example 8)
Affinity DataIC50:  14nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228629(US9345793, 10 | US9744252, Example 10)
Affinity DataIC50:  15nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228633(US9345793, 14 | US9744252, Example 14)
Affinity DataIC50:  15nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228624(US9345793, 5 | US9744252, Example 5)
Affinity DataIC50:  16nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228625(US9345793, 6 | US9744252, Example 6)
Affinity DataIC50:  16nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228622(US9345793, 3 | US9744252, Example 3)
Affinity DataIC50:  20nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228628(US9345793, 9 | US9744252, Example 9)
Affinity DataIC50:  21nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228621(US9345793, 2 | US9744252, Example 2)
Affinity DataIC50:  29nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228636(US9345793, 17 | US9744252, Example 17)
Affinity DataIC50:  35nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228623(US9345793, 4 | US9744252, Example 4)
Affinity DataIC50:  84nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM228620(US9345793, 1 | US9744252, Example 1)
Affinity DataIC50:  101nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50277111(3-Benzo[1,3]dioxol-5-yl-3-[1-oxo-6-(1,2,3,4-tetrah...)
Affinity DataIC50:  167nMAssay Description:Binding affinity to human integrin alpha2beta3 receptor by TRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50277112(3-[1-Oxo-6-(1,2,3,4-tetrahydro-benzo[4,5]imidazo[1...)
Affinity DataIC50:  323nMAssay Description:Binding affinity to human integrin alpha2beta3 receptor by TRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253816(CHEMBL460143 | Ethyl 2-(benzyl{2-[(4-carbamimidoyl...)
Affinity DataIC50:  730nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141994(US8927534, 269)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141990(US8927534, 266)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141986(US8927534, 262)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50423736(CHEMBL591543)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141981(US8927534, 120)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141973(US8927534, 114 | US8927534, 83)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141979(US8927534, 75)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141978(US8927534, 29)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141976(US8927534, 23)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141975(US8927534, 20)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50423721(CHEMBL595105)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM141972(US8927534, 11)
Affinity DataIC50: >1.00E+3nMpH: 9.6 T: 2°CAssay Description:Fibrinogen was diluted with coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and coated with 100 uL/well to Nunc-Immuno maxisorp plates over night...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253858(CHEMBL461210 | Ethyl 2-(benzyl{2-[(4-carbamimidoyl...)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253780(CHEMBL517875 | Ethyl 2-(benzyl{2-[(4-carbamimidoyl...)
Affinity DataIC50:  1.45E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253716((S)-3-{[2-(4-Carbamimidoyl-benzyloxy)-4-methyl-3-o...)
Affinity DataIC50:  1.64E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253313(4-{2-[(4-Carbamimidoylphenoxy)methyl]-2,4-dimethyl...)
Affinity DataIC50:  1.69E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253932(CHEMBL459318 | Ethyl 2-(N-{2-[(4-carbamimidoylphen...)
Affinity DataIC50:  1.78E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253817(CHEMBL460144 | Ethyl 2-(benzyl{2-[(4-carbamimidoyl...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253717(CHEMBL461191 | Ethyl 3-[2-(4-Carbamimidoylbenzylox...)
Affinity DataIC50:  2.44E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253311(CHEMBL494514 | N-{2-[(4-Carbamimidoylphenoxy)methy...)
Affinity DataIC50:  2.85E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50277098(3-[1-Oxo-6-(1,2,3,4-tetrahydro-benzo[4,5]imidazo[1...)
Affinity DataIC50:  6.30E+3nMAssay Description:Binding affinity to human integrin alpha2beta3 receptor by TRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253933(CHEMBL459524 | Methyl 2-benzyl-3-{2-[(4-carbamimid...)
Affinity DataIC50:  9.11E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50277097(3-(7-(2-amino-1-methyl-1H-benzo[d]imidazol-4-yloxy...)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to human integrin alpha2beta3 receptor by TRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50277095(3-(5-(2-amino-1-methyl-1H-benzo[d]imidazol-4-yloxy...)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to human integrin alpha2beta3 receptor by TRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50277096(3-(6-(2-amino-1-methyl-1H-benzo[d]imidazol-4-yloxy...)
Affinity DataIC50: >1.00E+4nMAssay Description:Binding affinity to human integrin alpha2beta3 receptor by TRF assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253900(CHEMBL468464 | Ethyl 4-({2-[(4-carbamimidoylphenox...)
Affinity DataIC50:  1.13E+4nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb(Homo sapiens (Human))
Piramal Imaging

US Patent
LigandPNGBDBM50253778(2-(4-Carbamimidoylbenzyloxy)-4-methyl-3-oxo-N-phen...)
Affinity DataIC50:  1.21E+4nMAssay Description:Inhibition of fibrinogen binding to human platelet GPIIb/IIIa receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: